支气管肺癌患者的中医治疗分析

Analysis of traditional Chinese medicine on bronchial lung cancer

目的探讨支气管肺癌患者的中医治疗方法及临床疗效。方法回顾性分析我院收治的60例支气管肺癌患者的临床资料,在常规治疗的基础上给予中医辨证治疗,观察患者的临床疗效、Karnofsky评分、肿瘤标志物变化情况及不良反应发生情况。结果治疗客观总有效率为58.33%(35/60),疾病总控制率为90.00%(54/60)。治疗后患者的Karnofsky评分显著高于治疗前(P<0.05),肿瘤标志物CEA和CA125水平均显著低于治疗前(P<0.05)。治疗过程中5例(8.33%)患者出现不良反应,经对症处理后症状消失或缓解。结论支气管肺癌的中医治疗效果好,有利于控制病情,延长患者生存期,且不良反应少,值得临床推广应用。

Objective To investigate the methods and clinical efficacy of traditional Chinese medicine on bronchial lung cancer. Methods The clinical data of 60 cases bronchial lung cancer patients admitted in our hospital were retrospectively analyzed. The Chinese medical syndrome typing treatment was taken on the basis of conventional treatment, and the clinical effect Karnofsky scores, tumor markers and adverse reactions of the patients were observed. Results The objective response rate （RR） was 58.33% （35/60）, and disease control rate （DC） was 90.00% （54/60）. After treatment, the Karnofsky score was significantly higher than that before treatment （P〈0.05）; the levels of CEA and CA125 were significantly lower than those before treatment （P 〈0.05）. There were 5 patients had adverse reactions, but the symptoms disappeared or relieved after symptomatic treatment. Conclusion Traditional Chinese medicine on bronchial lung cancer has significant clinical effect. It can control the disease development and prolong the survival period with little adverse reactions, which is worthy of promotion in clinic.